High Frequency of Aneuploidy Defines Ulcerative Colitis-Associated Carcinomas
Authors:
- Marco GerlingMGMarco Gerling
- Karl F. MeyerKMKarl F. Meyer
- Katrin FuchsKFKatrin Fuchs
- Bernd W. IglBIBernd W. Igl
- Britta FritzscheBFBritta Fritzsche
- Andreas ZieglerAZAndreas Ziegler
- F. BaderFBF. Bader
- Peter KujathPKPeter Kujath
- Hendrik SchimmelpenningHSHendrik Schimmelpenning
- Hans-Peter BruchHBHans-Peter Bruch
- Uwe J. RoblickURUwe J. Roblick
- Jens K. HabermannJHJens K. Habermann
- 1 July 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 252 (1) , 74-83
Abstract
Aneuploidy is an independent risk factor for forthcoming carcinogenesis in ulcerative colitis (UC). An inferior prognosis of patients with ulcerative colitis-associated colorectal cancer (UCC) compared with those with sporadic colorectal cancer (SCC) has been reported, but remains controversial. This prompted us to investigate if aneuploidy can be observed in UCCs as frequently as in their sporadic counterpart and if aneuploidy per se might be a driving feature of poor prognosis in UCC. We obtained clinical follow-up for 257 SCC patients (average observation time 57 months) and 31 UCC patients (51 months). Touch preparation slides or tissue sections were prepared of all 288 carcinomas for ploidy analysis. Ploidy status was assessed for 260 SCCs and 31 UCCs by image cytometry and correlated to clinical features. Survival data were analyzed using Kaplan-Meier estimates. Aneuploidy was detected in 74.6% of SCCs and in all 31 UCCs. Logistic regression analysis yielded age (odds ratio [OR], 1.05; 95% CI, 1.02-1.09; P = 0.003) and aneuploidy (OR, 4.07; 95% CI, 1.46-11.36; P = 0.007) as independent prognostic factors for R0-resected patients devoid of metastases. Diploid SCCs had a more favorable 5-year survival (88.2%) than aneuploid SCCs (69.0%) and UCCs (73.1%) (P = 0.074). UC-associated carcinomas presented aneuploidy at significantly higher frequency than sporadic colorectal carcinomas (P < 0.0006). UCCs and aneuploid SCCs share a similar prognosis inferior to that of diploid SCCs. Aneuploidy proved to be the strongest independent prognostic marker for R0-resected colorectal cancer patients overall.Keywords
This publication has 29 references indexed in Scilit:
- Dysplasia in ulcerative colitis?clinical consequences?Langenbeck's Archives of Surgery, 2004
- Ulcerative Colitis and Colorectal Carcinoma: DNA-Profile, Laminin-5 γ2 Chain and Cyclin A Expression as Early Markers for Risk AssessmentScandinavian Journal of Gastroenterology, 2001
- Cancer risk in patients with inflammatory bowel diseaseCancer, 2001
- How reliable/valid is dysplasia in identifying at-risk patients with ulcerative colitis?Journal of Gastrointestinal Surgery, 1998
- Comparative analysis of histology, DNA content,p53 and Ki-ras mutations in colectomy specimens with long-standing ulcerative colitisInternational Journal of Cancer, 1998
- Distribution of cell populations with DNA aneuploidy and p53 protein expression in ulcerative colitisEuropean Journal of Gastroenterology & Hepatology, 1997
- Failure of colonoscopic surveillance in ulcerative colitis.Gut, 1993
- DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitisGastroenterology, 1992
- DNA aneuploidy in ulcerative colitis: Reproducibility, topographic distribution, and relation to dysplasiaGastroenterology, 1992
- DNA aneuploidy in ulcerative colitis.Gut, 1986